ABIONYX Pharma SA
EPA:ABNX.PA
1.35 (EUR) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -3.518 | -4.206 | -5.822 | -1.886 | 1.849 | -6.305 | -4.978 | -24.871 | -16.638 | -6.563 | -7.742 |
| Depreciation & Amortization
| 0.153 | 0.135 | 0.119 | 0.022 | 0.013 | 0.039 | 0.043 | 0.048 | 0.056 | 0.088 | 0.156 |
| Deferred Income Tax
| 0 | 0 | -0.815 | -0.098 | -4.957 | 1.186 | -1.097 | -0.296 | -0.222 | 0.495 | 0.018 |
| Stock Based Compensation
| 0.02 | 0.506 | 0.815 | 0.098 | 0.098 | 0.033 | -0.731 | 5.398 | 0.511 | 0.369 | 0.97 |
| Change In Working Capital
| 0.538 | 0.097 | -1.744 | 2.13 | -1.304 | -0.316 | -0.895 | -0.733 | 1.23 | 1.619 | -5.963 |
| Accounts Receivables
| 0.384 | 0.036 | -0.095 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| -0.08 | 0.03 | 0.006 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | -0.036 | 0.095 | 1.215 | -0.837 | -0.575 | -3.657 | 0.604 | 0 | 0 | 0 |
| Other Working Capital
| 0.234 | 0.067 | -1.75 | 0.915 | -0.467 | 0.259 | 2.762 | -1.337 | 1.23 | 1.619 | -5.963 |
| Other Non Cash Items
| -0.891 | 0.109 | 0.755 | -0.865 | 0.351 | -0.638 | -2.531 | 0.961 | 1.13 | 1.184 | -1.914 |
| Operating Cash Flow
| -3.698 | -3.359 | -6.692 | -0.599 | -3.95 | -6.001 | -9.092 | -19.197 | -13.711 | -3.303 | -14.493 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -0.104 | -0.175 | -0.166 | -0.148 | 0 | -0.023 | -0.213 | -0.005 | -0.171 | -0.003 | -0.008 |
| Acquisitions Net
| 0 | 0 | 1.504 | 0.023 | 0 | 0.013 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| -0.026 | -0.01 | 1.501 | -0.022 | 0 | 0.013 | -0.213 | 0 | -0.01 | 0.004 | 0 |
| Investing Cash Flow
| -0.13 | -0.175 | 1.338 | -0.125 | 0 | -0.01 | -0.213 | -0.005 | -0.171 | 0.001 | -0.008 |
| Financing Activities: | |||||||||||
| Debt Repayment
| -0.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 4.186 | 0.042 | 4.056 | 1.836 | 0.973 | 1.195 | 0.152 | 0.925 | 49.478 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | -0.065 | -0.089 | 0 | 0 | 0 | 0 | -0.485 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | -0.2 | 3.972 | 1.547 | 0.25 | 1.195 | 0.75 | 0.925 | 49.478 | 0 | -0.75 |
| Financing Cash Flow
| 3.886 | -0.194 | 3.972 | 1.547 | 0.823 | 1.195 | 0.902 | 0.925 | 48.993 | 0 | -0.75 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0.001 | 0 | 0.001 | -0.002 | 0.004 | -0.002 |
| Net Change In Cash
| 0.058 | -3.728 | -1.382 | 0.823 | -3.126 | -4.815 | -8.403 | -18.276 | 35.108 | -3.298 | -15.253 |
| Cash At End Of Period
| 4.104 | 4.044 | 7.772 | 9.154 | 8.331 | 11.457 | 16.272 | 24.675 | 42.951 | 7.843 | 11.141 |